Free Trial

Outlook Therapeutics (OTLK) SEC Filings & 10K Form

Outlook Therapeutics logo
$6.27 -0.20 (-3.09%)
(As of 11/12/2024 ET)

Recent Outlook Therapeutics SEC Filings

DateFilerForm TypeView
10/03/2024
8:22 PM
Gangolli Julian S (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
THURMAN RANDY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
HILZINGER KURT J (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Faisal Ghiath (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
Haddadin Yezan Munther (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
Auffarth Gerd (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
Huang Andong (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
Haller Julia A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:53 PM
KENYON LAWRENCE A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:48 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
7:41 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
6:25 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form DEF 14A
05/15/2024
4:19 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
11:15 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form EFFECT
05/01/2024
5:02 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
3:18 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/17/2024
8:38 PM
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Syntone Ventures LLC (Filed by)
Form SC 13D/A
04/17/2024
7:21 PM
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Syntone Ventures LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
4:21 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
04/15/2024
3:53 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2024
3:27 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 424B5
04/07/2024
11:15 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form EFFECT
04/02/2024
3:15 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
11:15 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form EFFECT
04/01/2024
3:53 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 424B3
03/29/2024
1:16 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
03/29/2024
9:39 AM
Haddadin Yezan Munther (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:00 PM
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13G
03/26/2024
3:20 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:11 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/22/2024
4:00 PM
KENYON LAWRENCE A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
4:00 PM
Evanson Jeff (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
4:00 PM
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
TRENARY C RUSSELL III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
4:24 PM
GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Form SC 13D/A
03/20/2024
4:20 PM
GMS Ventures & Investments (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Ghiath M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:14 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
3:43 PM
Evanson Jeff (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:18 PM
Huang Andong (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
5:59 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form DEF 14A
02/08/2024
6:00 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form ARS
01/24/2024
5:02 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

12/22/2023
4:00 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/06/2023
4:00 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:OTLK) was last updated on 11/12/2024 by MarketBeat.com Staff
From Our Partners